Molecular Target Synopsis
Overview
Domains and Structures
Drugs and Clinical Candidates
Druggability
Chemistry
Ligand Efficiency Plot
Pathways
Family Cladogram
Interaction Network
Gene Expression
Gene Copy Number Variation
RNAi
Mutations
Germline Genetics

BTG2 (P78543) - Druggability - Molecular Target Synopsis

Chain-based assessment (last updated 23/07/2019)
Domain-based assessment (last updated 30/07/2012)


Structural Druggability Help: Help

Chain-based assessment (last updated 23/07/2019)


Chains assessed2
Chains with at least one site assessed as druggable using the strict criteria0
Chains with at least one site assessed as druggable using the relaxed criteria2


		
PDB Chain Protein Name Druggable Relaxed Druggable Strict Details
3E9V_A Protein BTG2 Yes No show/hide
Site num Site Status Pickpocket Polar Ratio Surfnet Gap Vertices Buried Surfnet Long Axis Druggable Relaxed Druggable Strict
1 bound 1.98 72 14.4 Yes No
2 empty 2.41 65.2 11.7 No No
3 empty 1.73 63.3 12.8 No No
4 empty 2.19 63.5 11.5 No No
5 empty 2.5 65.3 11.9 No No
6 empty 1.92 73.7 9.5 No No
7 empty 1.76 53.3 11.2 No No
8 empty 1.98 65.1 7.7 No No
9 empty 2.22 61.5 9.9 No No
10 empty 2.42 46 7.7 No No
3DJU_B Protein BTG2 Yes No show/hide
Site num Site Status Pickpocket Polar Ratio Surfnet Gap Vertices Buried Surfnet Long Axis Druggable Relaxed Druggable Strict
1 empty 1.75 74.9 11 Yes No
2 empty 2.62 66.7 13.2 No No
3 empty 1.93 60.3 14.3 No No
4 empty 2.02 60.8 14.4 No No
5 empty 2.09 59.9 13.6 No No
6 empty 2.42 72 10.6 No No
7 empty 2.44 62.2 13.8 No No
8 empty 2.66 66.7 9.7 No No
9 empty 2.09 58.9 12.3 No No
10 empty 2.78 64.2 10.5 No No

Domain-based assessment (last updated 30/07/2012)


Domains assessed2
Domains assessed as druggable using the strict criteria0
Domains assessed as druggable using the relaxed criteria2

PDB (Domain) Protein Name Domain Resolution Ligands Druggable Relaxed Druggable Strict
3DJU_B (3360481) Protein BTG2 BTG domain-like, BTG domain-like, UNMATCHED 2.26Å Yes No
3E9V_A (158072) Protein BTG2 BTG domain-like, BTG domain-like, BTG domain-like 1.7Å Yes No
Ligand-based Druggability Score: -3
Ligand-based Druggability Score Percentile: 59%
Ligand-based Druggability Help: Help




		
Number of proteins in the network : 13346


BTG2 is involved in 14 interactions in the network.


Druggability
Overall Druggability Percentile: 64.95
Druggability for Cancer Therapeutics: 59.09
Druggability for Other Therapeutics: 41.98
Cancer-Associated
Cancer-associated percentile : 84.55
Network Articulation Point
Is BTG2 critical for communication in the network?


Detailed Graph Legend:Help